261 related articles for article (PubMed ID: 19211447)
21. Breast cancer risk and the administration of human hormones. Part I. Hormone replacement therapy.
Mann RD
Adverse Drug React Toxicol Rev; 1992; 11(3):149-72. PubMed ID: 1391392
[No Abstract] [Full Text] [Related]
22. Hormone therapy: making decisions in the face of uncertainty.
Peterson HB; Thacker SB; Corso PS; Marchbanks PA; Koplan JP
Arch Intern Med; 2004 Nov; 164(21):2308-12. PubMed ID: 15557408
[No Abstract] [Full Text] [Related]
23. Hormone replacement therapy, breast and endometrial cancer.
La Vecchia C
Eur J Cancer Prev; 1996 Oct; 5(5):414-6. PubMed ID: 8972283
[No Abstract] [Full Text] [Related]
24. [Hormone replacement therapy and breast cancer].
Mueck AO
Med Monatsschr Pharm; 2002 Oct; 25(10):337-47. PubMed ID: 12404946
[No Abstract] [Full Text] [Related]
25. Does the decrease in hormone replacement therapy also affect breast cancer risk in the Netherlands?
Soerjomataram I; Coebergh JW; Louwman MW; Visser O; van Leeuwen FE
J Clin Oncol; 2007 Nov; 25(31):5038-9; author reply 5039-40. PubMed ID: 17971608
[No Abstract] [Full Text] [Related]
26. Oral contraceptives and breast cancer risk.
Ansink AC; Burger CW
J Clin Oncol; 2007 Nov; 25(33):5327; author reply 5327-8. PubMed ID: 18024881
[No Abstract] [Full Text] [Related]
27. Five families living with hereditary breast and ovarian cancer risk.
Norris J; Spelic SS; Snyder C; Tinley S
Clin J Oncol Nurs; 2009 Feb; 13(1):73-80. PubMed ID: 19193551
[TBL] [Abstract][Full Text] [Related]
28. Genetic services have value beyond BRCA1/2 testing.
Hall MJ
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):686. PubMed ID: 19208665
[No Abstract] [Full Text] [Related]
29. [Hormone replacement therapy in postmenopausal women and breast cancer risk: impact of estrogens deprivation and timing hypothesis].
Brettes JP; Mathelin C
Gynecol Obstet Fertil; 2007 Nov; 35(11):1092-4. PubMed ID: 17996474
[No Abstract] [Full Text] [Related]
30. [The breast cancer risk in postmenopausal estrogen substitution. The dilemma of risk assessment].
Lippert TH; Mück AO
Dtsch Med Wochenschr; 1997 Jul; 122(28-29):908-11. PubMed ID: 9264923
[No Abstract] [Full Text] [Related]
31. Male to female ratio among offspring of BRCA1 mutation carriers.
Gronwald J; Byrski T; Huzarski T; Narod SA; Lubinski J
Breast Cancer Res Treat; 2006 May; 97(1):113-4. PubMed ID: 16319974
[No Abstract] [Full Text] [Related]
32. [Use of hormone-replacement therapy and steroid contraceptives in menopause as an oncological and epidemiological problem: is it a risk and/or benefit?].
Bershteĭn LM
Vopr Onkol; 2005; 51(6):636-46. PubMed ID: 17037027
[No Abstract] [Full Text] [Related]
33. Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer.
Forman AD; Hall MJ
Breast J; 2009; 15 Suppl 1():S56-62. PubMed ID: 19775331
[TBL] [Abstract][Full Text] [Related]
34. Pros and cons. Hormone therapy can do wonders for women, but a new cancer study underscores the risks.
Nash JM
Time; 2000 Feb; 155(5):68-9. PubMed ID: 10787970
[No Abstract] [Full Text] [Related]
35. Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007.
Schwartz GF; Hughes KS; Lynch HT; Fabian CJ; Fentiman IS; Robson ME; Domchek SM; Hartmann LC; Holland R; Winchester DJ;
Cancer; 2008 Nov; 113(10):2627-37. PubMed ID: 18853415
[TBL] [Abstract][Full Text] [Related]
36. Is combined estrogen/progestogen hormone therapy worth the risk?
Sturdee DW; MacLennan AH
Climacteric; 2003 Sep; 6(3):177-9. PubMed ID: 14567764
[No Abstract] [Full Text] [Related]
37. Breast cancer and hormonal therapy.
Conner P; Lundström E; von Schoultz B
Clin Obstet Gynecol; 2008 Sep; 51(3):592-606. PubMed ID: 18677153
[TBL] [Abstract][Full Text] [Related]
38. [Relationship between mutation of BRCA1 and susceptibility to early onset of breast cancer].
Meng J; Shi YR; Niu RF; Fu L
Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(2):79-82. PubMed ID: 19489266
[TBL] [Abstract][Full Text] [Related]
39. [Hormone therapy and breast cancer].
Olsen J
Ugeskr Laeger; 2003 Sep; 165(38):3631-2. PubMed ID: 14556398
[No Abstract] [Full Text] [Related]
40. [Breast cancer risk with hormone replacement therapy. A matter of interpretation].
Röhm W
MMW Fortschr Med; 2004 Feb; 146(6):15; author reply 15. PubMed ID: 15035307
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
